Apothecary Pharma Recalls Tirzepatide Injection Vials Due to Sterility Concerns
Apothecary Pharma LLC is recalling 22 vials of Tirzepatide Injection due to a lack of assurance of sterility. The affected product was distributed nationwide.
- Product
- Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18.
- Category
- Drug
- Distribution
- Distributed nationwide